HG-004 | Interleukin Related interleukin-related.com

Product Name :
HG-004

Search keywords :
p63

drugId :
null

Target Vo:
Retinoid isomerohydrolase

Target Vo Short Name :
RPE65

Moa_Name:
Gene modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
HuiGene Therapeutics Ltd

Active Company_Name :
HuidaGene Therapeutics Co Ltd

Active Indication_Name:
Leber Congenital Amaurosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Figitumumab web
Ki-67 Antibody Purity & Documentation
Cyclin B2 Antibody: Cyclin B2 Antibody is an unconjugated, approximately 45 kDa, anti-Cyclin B2 monoclonal antibody. Cyclin B2 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts